Volume 18 - Issue 11 - November, 2006
Feature
Original Contribution
08/01/2008
aStephen Worthley, MBBS, PhDH, bM. Omar Farouque, MBBS, PhD, aMatthew Worthley, MBBS, PhD, bMauro Baldi, BSc, cDerek Chew, MBBS, MPH, bIan Meredith, MBBS, PhD
aStephen Worthley, MBBS, PhDH, bM. O...
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in most patients with acute coronary syndromes (ACS) is culprit lesion disruption with associated thrombosis.1 There is an increasing body of evidence showing that these culprit lesions, the so-called “vulnerable”...
The underlying pathobiology in...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Ravi K. Ramana, DO, Dominique Joyal, MD, Dinesh Arab, MD, Robert S. Dieter, MD, RVT,
Lowell Steen, MD, Bruce Lewis, MD, Ferdinand Leya, MD
Ravi K. Ramana, DO, Dominique Joyal,...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have...
08/01/2008
Journal of Invasive Cardiology
